Erosive Gastroesophageal Reflux Disease (eGERD) research hub

A Phase I trial to investigate the pharmacokinetics and ECG effects of single doses of linaprazan glurate administered as oral tablets to healthy participants

This early-stage study is looking at a new medicine called linaprazan glurate. We want to see how it moves through the body and how it affects the heart in healthy volunteers. The aim is to check its safety and how it works before trying it in people with a condition called eGERD.